Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia
by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement
Updated on: April 01,2024
18

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia
by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement
Updated on:April 01,2024
18
